Favorable outcome of PML‐RARα short isoform and FLT3‐ITD mutation in a patient with several adverse prognostic markers: A case report

KEY CLINICAL MESSAGE: Complete molecular remission in a “variant APL” patient with short isoform of PML‐RARα and FLT3‐ITD mutation was achieved in response to ATRA and ATO plus IDA instead of standard treatment protocol. The use of FLT3 inhibitor in APL induction management is implicated to prevent...

Descripción completa

Detalles Bibliográficos
Autores principales: Bafail, Mohammed A., AlTahan, Rahaf, Samman, Manar A., Tashkandi, Suha A., Motabi, Ibraheem H., Peer‐Zada, Abdul Ali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323718/
https://www.ncbi.nlm.nih.gov/pubmed/37426684
http://dx.doi.org/10.1002/ccr3.7637

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10323718/
https://www.ncbi.nlm.nih.gov/pubmed/37426684
http://dx.doi.org/10.1002/ccr3.7637

Ejemplares similares